Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Immuron Ltd changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 3 | 5 | +2 |
| Shares | 6.10K | 23.0K | +16.9K (+277.8%) |
| Value | $10.8K | $40.1K | +$29.3K (+271.3%) |
New holders (3)
Institutions that held Immuron Ltd at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 16,295 | $28.4K | 0.00% |
| Morgan Stanley | 700 | $1.22K | 0.00% |
| BNP Paribas Arbitrage, SA | 100 | $174 | 0.00% |
Sold out (1)
Institutions that held Immuron Ltd at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Wells Fargo & Company | 150 | $270 |